Cargando…
A phase 1, randomized, open-label, single-dose study to assess the relative bioavailability of a subcutaneous dose of FKB327 when administered using a prefilled syringe, a prefilled auto-injector, or a vial with disposable syringe in healthy subjects
BACKGROUND/OBJECTIVE: FKB327 is a biosimilar of the adalimumab reference product (RP). The primary objective was to assess the relative bioavailability of FKB327 after a single subcutaneous (SC) dose via prefilled syringe (PFS), auto-injector (AI), or vial with a disposable syringe (vial), in health...
Autores principales: | Bush, Jim, Kawakami, Kazuki, Muniz, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937755/ https://www.ncbi.nlm.nih.gov/pubmed/31888742 http://dx.doi.org/10.1186/s40360-019-0376-9 |
Ejemplares similares
-
Prefilled syringes: An innovation in parenteral packaging
por: Makwana, Sagar, et al.
Publicado: (2011) -
Prefilled syringes for intravitreal drug delivery
por: Sassalos, Thérèse M, et al.
Publicado: (2019) -
Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects
por: Struemper, Herbert, et al.
Publicado: (2015) -
Prefilled syringes and usability of ophthalmic viscosurgical devices
por: Shiba, Takuya, et al.
Publicado: (2014) -
Impact of Prefilled Syringes and Masking on Postintravitreal Injection Endophthalmitis
por: Louis, Abigail M., et al.
Publicado: (2023)